摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

[5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)-3,4-dihydro-2H-chromen-3-yl] 4-hydroxybenzoate

中文名称
——
中文别名
——
英文名称
[5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)-3,4-dihydro-2H-chromen-3-yl] 4-hydroxybenzoate
英文别名
——
[5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)-3,4-dihydro-2H-chromen-3-yl] 4-hydroxybenzoate化学式
CAS
——
化学式
C22H18O9
mdl
——
分子量
426.4
InChiKey
KRGDXHCBNLBSJP-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.9
  • 重原子数:
    31
  • 可旋转键数:
    4
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.14
  • 拓扑面积:
    157
  • 氢给体数:
    6
  • 氢受体数:
    9

文献信息

  • (-)-Epigallocatechin Gallate Derivatives For Inhibiting Proteasome
    申请人:Chan Tak-Hang
    公开号:US20080176931A1
    公开(公告)日:2008-07-24
    (−)-EGCG, the most abundant catechin, was found to be chemopreventive and anticancer agent. However, (−)-EGCG has at least one limitation: it gives poor bioavailability. This invention provides compounds of generally formulae below, wherein R 11 , R 12 , R 13 , R 21 , R 22 , R 2 , R 3 , and R 4 are each independently selected from the group consisting of —H, and C 1 to C 10 acyloxyl group; and R 5 is selected from the group consisting of —H, C 1 -C 10 -alkyl, C 2 -C 10 -alkenyl, C 2 -C 10 -alkynyl, C 3 -C 7 -cycloalkyl, phenyl, benzyl and C 3 -C 7 -cycloalkenyl, whereas each of the last mentioned 7 groups can be substituted with any combination of one to six halogen atoms; at least one of R 11 , R 12 , R 13 , R 21 , R 22 , R 2 , R 3 and R 4 is —H, which were found to be more potent than their non-protected counterparts, which can be used as proteasome inhibitors to reduce tumor cell growth.
    (-)-EGCG是最丰富的儿茶素之一,被发现具有化学预防和抗癌作用。然而,(-)-EGCG至少存在一个限制:其生物利用度较低。本发明提供了一般化学式如下的化合物,其中R11、R12、R13、R21、R22、R2、R3和R4各自独立地选择自-H和C1到C10酰氧基的群组成;而R5选择自-H、C1-C10烷基、C2-C10烯基、C2-C10炔基、C3-C7环烷基、苯基、苄基和C3-C7环烯基,而最后提到的7个基团中的每一个都可以用任意组合的1到6个卤素原子取代;其中至少有一个是R11、R12、R13、R21、R22、R2、R3和R4中的-H,这些化合物比其非保护的对应物更有效,可用作蛋白酶抑制剂来减少肿瘤细胞生长。
  • (-)-Epigallocatechin Gallate Derivatives for Inhibiting Proteasome
    申请人:CHAN Tak-Hang
    公开号:US20120232135A1
    公开(公告)日:2012-09-13
    A method of reducing tumor cell growth, the method including administering an effective amount of a compound having the formula:
    一种减少肿瘤细胞生长的方法,包括给予一种具有以下化学式的化合物的有效剂量:
  • (-)-EPIGALLOCATECHIN GALLATE DERIVATIVES FOR INHIBITING PROTEASOME
    申请人:The Hong Kong Polytechnic University
    公开号:US20160068503A1
    公开(公告)日:2016-03-10
    A method of reducing tumor cell growth, the method including administering an effective amount of a compound having the formula:
    一种减少肿瘤细胞生长的方法,该方法包括给予一种具有以下公式的化合物的有效量:
  • US8193377B2
    申请人:——
    公开号:US8193377B2
    公开(公告)日:2012-06-05
  • US8710248B2
    申请人:——
    公开号:US8710248B2
    公开(公告)日:2014-04-29
查看更多